Core Scientific Creations

Company Overview

Snapshot

Founded in October 2012 by Damian Delfino and Yuval Yaskil, Core Scientific Creations operates with 11–50 employees. The company specializes in advanced bleeding control medical devices, notably its WoundClot product. In February 2018, Core Scientific Creations expanded its global reach, selling WoundClot and other medical supplies to distributors in 32 countries, signaling strong international market penetration for its innovative hemostatic solutions.

Business overview

Core Scientific Creations develops and manufactures advanced medical devices for bleeding control, with its flagship product being WoundClot. This non-oxidized cellulose hemostat is engineered to manage mild, moderate, and severe bleeding across various settings, including vascular, soft tissue, bone, and traumatic hemorrhages. The company serves the health tech and life sciences sector, providing solutions for both inpatient and outpatient care, and is applicable for use by medical professionals and untrained caregivers alike. Its products are utilized in hospitals, home care, surgery, and military applications.

Strategic signal

In February 2018, Core Scientific Creations announced the global sale of its WoundClot bandage and other medical supplies to distributors in 32 countries. This expansion indicates significant international market validation and a robust distribution network for its bio-absorbable hemostat technology. For investors, this signals a strong growth trajectory and increasing adoption of its innovative bleeding control solutions across diverse healthcare and emergency response markets worldwide.

Company Intelligence Q&A

What is WoundClot and its primary function?

WoundClot is a non-oxidized cellulose hemostat developed by Core Scientific Creations. It is designed to quickly and safely control all types of bleeding, including severe arterial bleeding, by creating a biological clot that is fully absorbed by the body within seven days. It also promotes coagulation for coagulopathic patients.

Which markets does Core Scientific Creations serve with its WoundClot product?

Core Scientific Creations serves a broad range of markets, including battle settings, surgical and trauma care, and general medical applications. Its WoundClot bandage is provided to entities such as Israeli police forces, the army, and hospitals, and is sold to distributors in 32 countries globally.

When did Core Scientific Creations expand its global sales for WoundClot?

In February 2018, Core Scientific Creations expanded its global sales, distributing WoundClot and other medical supplies to distributors in 32 countries.

What unique features does WoundClot offer compared to other hemostatic products?

WoundClot is unique because it is a non-compressional, bio-absorbable hemostat that remains biologically active for 24-36 hours. It is also the only bio-absorbable hemostat currently approved for severe arterial bleeding, and it promotes coagulation for coagulopathic patients.

What was the company's status regarding investment in early 2018?

In February 2018, Core Scientific Creations was in the final stages of a capital round, seeking investment from venture capital firms to support its growth and manufacturing capacity.